A detailed history of Dunhill Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Dunhill Financial, LLC holds 710 shares of ABBV stock, worth $117,142. This represents 0.07% of its overall portfolio holdings.

Number of Shares
710
Previous 237 199.58%
Holding current value
$117,142
Previous $40.7 Million 244.9%
% of portfolio
0.07%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$163.84 - $199.33 $77,496 - $94,283
473 Added 199.58%
710 $140 Million
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $6,036 - $7,049
39 Added 19.7%
237 $40.7 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $4,794 - $5,463
30 Added 17.86%
198 $36.1 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $23,116 - $26,034
168 New
168 $26.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.